Zdrowie i gospodarka · 29/07/2026
FDA Announces Availability of Revised Draft Product-Specific Guidances
The FDA is releasing additional revised draft product-specific guidances, which provide recommendations on bioequivalence studies to support abbreviated new drug applications, following the process outlined in a 2010 guidance.